51 – 60 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children
(
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Maternal dietary supplement use and development of islet autoimmunity in the offspring : TEDDY study
(
- Contribution to journal › Article
-
Mark
Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors : Results from the prospective TEDDY study
(
- Contribution to journal › Article
-
Mark
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children
(
- Contribution to journal › Article
-
Mark
Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families
(
- Contribution to journal › Article
-
Mark
Early probiotic supplementation and the risk of celiac disease in children at genetic risk
(
- Contribution to journal › Article
-
Mark
Association of gluten intake during the first 5 years of life with incidence of celiac disease autoimmunity and celiac disease among children at increased risk
(
- Contribution to journal › Article
-
Mark
Prospective virome analyses in young children at increased genetic risk for type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
(
- Contribution to journal › Article